Cardiac Wire #197 August 1, 2024
Obicetrapib Cuts LDL-C | First Total Artificial Heart
Cardiac Wire #196 July 29, 2024
Edwards Acquisition Spree | Wegovy’s EU Expansion
Cardiac Wire #195 July 25, 2024
Magenta’s MCS Disruption | REVIVED CAD Evidence
Cardiac Wire #194 July 22, 2024
AFib Wearables’ Psychological Impact | Interactive Plaque
Cardiac Wire #193 July 18, 2024
Lexeo’s FA Cardiomyopathy Promise | Edwards Mitral Mission
Cardiac Wire #192 July 15, 2024
Huge Concurrent Settlement | Just Get the ECG | Life After MI
Cardiac Wire #191 July 11, 2024
Cardiology Deserts | Farapulse Safety
Cardiac Wire #190 July 8, 2024
Aging and Asymptomatic VHD | Private Equity’s Cardiology Expansion
Cardiac Wire #189 July 1, 2024
Cardiology in H1 2024 | Amvuttra’s ATTR-CM Impact
Cardiac Wire #188 June 27, 2024
Regenerating The Myocardium | Zerlasiran’s LP(a) Potential
Cardiac Wire #187 June 24, 2024
Echo AI Streamlines MR | BaroPace’s HFpEF Device
Cardiac Wire #186 June 20, 2024
Marea Cardiometabolic Mission | Pregnancy Hypertension Rising
Cardiac Wire #185 June 17, 2024
Private Equity Targets Cardiology | Nickel-less TAVR
Cardiac Wire #184 June 13, 2024
Redefining Statin Eligibility | HF Detection Gets Smart
Cardiac Wire #183 June 10, 2024
Edwards’ Small Annulus Outcomes | Xylitol’s CVD Aftertaste
Cardiac Wire #182 June 6, 2024
Integrated Echo AI | Heart Disease in 2050
Cardiac Wire #181 June 3, 2024
Statins in Older Patients | Mummified CVD
Cardiac Wire #180 May 30, 2024
Disappearing Cardiology Practices | Experience-Exposure Paradox
Cardiac Wire #179 May 23, 2024
